Naveen  Bhatia net worth and biography

Naveen Bhatia Biography and Net Worth

Director of LifeMD
Naveen Bhatia is a private investor. From 2013 to 2020, he was a Senior Director in the Tactical Opportunities Group of Blackstone, a leading global investment business specializing in alternative asset classes.
Before joining Blackstone, Naveen was a Managing Director at 40 North Industries LLC, a private investment firm where he focused on special situations equity and debt investments, both public and private. Prior to 40 North, he was a Principal at a family office in New York. From 2003 to 2008, Naveen was a Co-Founder and Partner of Eagle Lake Capital LLC, a private investment partnership focused on fundamental, value investing across the capital structure. He started his career as a member of the Restructuring Group at Rothschild.

Naveen received a BA in Public Health from The Johns Hopkins University. He has served as a director of various public and private companies, currently serving as a member of the Board of Directors of Blue Yonder, EquipmentShare, RG Barry, and CRG Financial. From 2010-2019, Naveen served as Chairman of the Board of Cotton Holdings, a leading global infrastructure support services company. He was also an Adjunct Professor at Columbia Business School and taught Applied Security Analysis I & II for eight years.

What is Naveen Bhatia's net worth?

The estimated net worth of Naveen Bhatia is at least $1.24 million as of May 18th, 2022. Mr. Bhatia owns 246,349 shares of LifeMD stock worth more than $1,241,599 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Bhatia may own. Learn More about Naveen Bhatia's net worth.

How do I contact Naveen Bhatia?

The corporate mailing address for Mr. Bhatia and other LifeMD executives is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. LifeMD can also be reached via phone at (866) 351-5907 and via email at [email protected]. Learn More on Naveen Bhatia's contact information.

Has Naveen Bhatia been buying or selling shares of LifeMD?

Naveen Bhatia has not been actively trading shares of LifeMD over the course of the past ninety days. Most recently, on Wednesday, May 18th, Naveen Bhatia bought 50,000 shares of LifeMD stock. The stock was acquired at an average cost of $2.14 per share, with a total value of $107,000.00. Following the completion of the transaction, the director now directly owns 246,349 shares of the company's stock, valued at $527,186.86. Learn More on Naveen Bhatia's trading history.

Who are LifeMD's active insiders?

LifeMD's insider roster includes Marc Benathen (CFO), Naveen Bhatia (Director), Corey Deutsch (Insider), Joseph DiTrolio (Director), Stefan Galluppi (CTO), Justin Schreiber (CEO), Bertrand Velge (Director), Happy Walters (Director), and Eric Yecies (General Counsel). Learn More on LifeMD's active insiders.

Are insiders buying or selling shares of LifeMD?

In the last twelve months, LifeMD insiders bought shares 1 times. They purchased a total of 3,000 shares worth more than $14,790.00. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 25,000 shares worth more than $163,000.00. The most recent insider tranaction occured on December, 2nd when CEO Justin Schreiber sold 25,000 shares worth more than $163,000.00. Insiders at LifeMD own 16.0% of the company. Learn More about insider trades at LifeMD.

Information on this page was last updated on 12/2/2024.

Naveen Bhatia Insider Trading History at LifeMD

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2022Buy50,000$2.14$107,000.00246,349View SEC Filing Icon  
11/30/2021Buy50,000$3.88$194,000.00View SEC Filing Icon  
See Full Table

Naveen Bhatia Buying and Selling Activity at LifeMD

This chart shows Naveen Bhatia's buying and selling at LifeMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LifeMD Company Overview

LifeMD logo
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Read More

Today's Range

Now: $5.04
Low: $4.76
High: $5.17

50 Day Range

MA: $5.38
Low: $4.08
High: $7.16

2 Week Range

Now: $5.04
Low: $3.99
High: $12.88

Volume

1,333,244 shs

Average Volume

742,021 shs

Market Capitalization

$218.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38